Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors

​ Conditions: Tumor, Solid

Interventions: Drug: RGL-270 Injection; Drug: Adebelimab Injection

Sponsors: Xian-Jun Yu

Recruiting Conditions: Tumor, Solid
Interventions: Drug: RGL-270 Injection; Drug: Adebelimab Injection
Sponsors: Xian-Jun Yu
Recruiting